Amimestrocel Injection Application Scope

Amimestrocel is indicated for the treatment of steroid-refractory acute graft-versus-host disease (aGVHD) with predominant gastrointestinal involvement in patients aged 14 years and older.

Amimestrocel Injection Characteristics

Ingredients: Amimestrocel (allogeneic mesenchymal stem cells / MSC-based therapy).
Properties: Colorless to slightly yellow clear liquid, free of foreign matter and precipitation.
Packaging Specification: 3.8 ml × 1 vial.
Storage: Store at 2-8°C under refrigeration, avoid freezing and exposure to light.
Expiry Date: As indicated on the label; stability depends on cryopreservation conditions.
Executive Standard: In accordance with relevant cell therapy GMP regulations and clinical guidelines.
Approval Number: As indicated on the packaging.
Date of Revision: As indicated on the packaging.
Manufacturer: As indicated on the packaging.

Guidelines for the Use of Amimestrocel Injection

Dosage and Administration:
- Recommended Dose: Determined by the prescribing physician based on clinical trial protocol or treatment guidelines.推
- Administration: Administered intravenously under medical supervision in a certified healthcare facility.
- Missed Dose: If a scheduled infusion is missed, consult the prescribing physician immediately.
Adverse Reactions:
- Common Adverse Reactions: Transient fever, headache, chills, mild infusion-related reactions.
- Serious Adverse Reactions: Rare; may include severe allergic reaction, immune response, or infection related to cell infusion.
Contraindications:
- Known hypersensitivity to any excipients.
- Active systemic infection.
- Severe uncontrolled comorbidities as assessed by the physician.
Precautions:
- Use only under the supervision of a qualified specialist.
- Monitor patients closely during and after infusion.
- Ensure proper screening of patients before administration.

Amimestrocel Injection Interactions

No confirmed drug–drug interactions established to date.
Caution is advised when combined with immunosuppressive or immunomodulatory therapies; physician evaluation is required.

Note:

If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from DengYue Medicine.
This content is for reference only. Prescription drugs must be used under a doctor’s guidance and purchased from authorized sources.